FRIDAY, Feb. 21, 2025 -- For patients with previously untreated chronic lymphocytic leukemia (CLL)...
Author - David Miller
Arrowhead Pharmaceuticals Submits New Drug Application to U.S...
PASADENA, Calif.–(BUSINESS WIRE)–Nov. 18, 2024– Arrowhead Pharmaceuticals, Inc. (NASDAQ:...
Applied Therapeutics Receives Complete Response Letter from U.S...
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a...
Olpasiran Leads to Significant Reduction in Oxidized...
FRIDAY, Feb. 21, 2025 -- Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a])...
Black Patients With Cancer Still Have Higher Mortality Rates...
FRIDAY, Feb. 21, 2025 -- Cancer mortality has decreased among Black Americans, but they still have...
Satsuma Pharmaceuticals and SNBL Receive FDA Acceptance of NDA...
DURHAM, N.C., Nov. 26, 2024 /PRNewswire/ — Satsuma Pharmaceuticals, Inc., a late-stage...
Saol Therapeutics Announces Submission of New Drug Application...
ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Dec. 3, 2024 /PRNewswire/ — Saol Therapeutics...
Postpandemic Hospital Occupancy Up to 73.5 Percent, Sparking...
FRIDAY, Feb. 21, 2025 -- Postpandemic hospital occupancy is higher than prepandemic and is expected...
Cytokinetics Announces FDA Acceptance of New Drug Application...
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated...
At 10 Years, Roux-en-Y Gastric Bypass Superior for Patient...
MONDAY, Feb. 24, 2025 -- The long-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric...